Ceryvyn Therapeutics Limited Profit Margin

As of the most recent data (December 2025), CKDXF shows a profit margin of 59132.21%. That compares with -136844.49% in the prior-year period — up 143.2% year over year. That is above the Healthcare sector average of 9.48%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CKDXF's profit margin is now 59132.21% (was -136844.49%) — a 143.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Ceryvyn Therapeutics Limited is outperforming or lagging.

The Healthcare sector average profit margin is about 9.48%. Ceryvyn Therapeutics Limited is at 59132.21%, which is higher that average. That is roughly 623594.2% above the sector mean. Use the comparison chart on this page to see how CKDXF stacks up against individual peers as well.

That compares with -136844.49% in the prior-year period — up 143.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Ceryvyn Therapeutics Limited with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Ceryvyn Therapeutics Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 59132.21%) with ownership activity and broader fundamentals.